NEWS FLASH

FDA Panel Recommends HIV Prevention Drug | Last night, an FDA advisory committee voted 19-3 to endorse the drug Truvada for use in controlling HIV infection among men who have sex with men, including preventive use by men who are partnered with someone who is HIV-positive. This would be the first drug ever marketed for HIV prevention, a process known as pre-exposure prophylaxis (PrEP). FDA regulators still have to give final consideration to the recommendation before Truvada can be distributed.